Targretin
Term · Oncology and biomedicine · MLC-T-ONC-008526
A drug used to treat skin problems caused by cutaneous T-cell lymphoma that did not get better after other treatment. It is also being studied in the treatment of other types of cancer. Targretin binds to and activates proteins called retinoid X receptors, which may stop the growth of cancer cells and kill them. It is a type of retinoid. Also called bexarotene and LGD1069.
| Identifier | MLC-T-ONC-008526 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | bexarotene; LGD1069 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008526",
"term": "Targretin",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat skin problems caused by cutaneous T-cell lymphoma that did not get better after other treatment. It is also being studied in the treatment of other types of cancer. Targretin binds to and activates proteins called retinoid X receptors, which may stop the growth of cancer cells and kill them. It is a type of retinoid. Also called bexarotene and LGD1069.",
"synonyms": [
"bexarotene",
"LGD1069"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/targretin/"
}
Record 16,002 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.